Promino Nutritional Sciences Inc

FRA:93X (Canada)   Ordinary Shares
€ 0.16 (-11.11%) May 23
At Loss
Market Cap:
€ 7.86M ($ 8.53M)
Enterprise V:
€ 9.75M ($ 10.57M)
Volume:
7.61K
Avg Vol (2M):
21.61K
Also Trade In:

Business Description

Description
Promino Nutritional Sciences Inc is a nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate, is a patented proprietary formula that assists in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Promino also offers Promino, a performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -52.93
Debt-to-Equity -0.33
Debt-to-EBITDA -0.53
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -497.28
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.58
9-Day RSI 47.13
14-Day RSI 51.15
6-1 Month Momentum % 41.03
12-1 Month Momentum % -44.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.02
Quick Ratio 0.02
Days Inventory 242.98
Days Sales Outstanding 40.47
Days Payable 1222.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.9
Shareholder Yield % -12.91
Name Current Vs Industry Vs History
Gross Margin % -291.63
Operating Margin % -1194.56
Net Margin % -1214.85
FCF Margin % -375.76
ROA % -268.84
ROIC % -327.78
ROC (Joel Greenblatt) % -7508.5

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 17.92
EV-to-EBIT -2.72
EV-to-EBITDA -2.74
EV-to-Revenue 30.22
EV-to-FCF -8.06
Earnings Yield (Greenblatt) % -36.76
FCF Yield % -15.4

Financials

FRA:93X's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Promino Nutritional Sciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.33
EPS (TTM) (€) -0.1
Beta 0
Volatility % 118.46
14-Day RSI 51.15
14-Day ATR (€) 0.016593
20-Day SMA (€) 0.163275
12-1 Month Momentum % -44.61
52-Week Range (€) 0.054 - 0.501
Shares Outstanding (Mil) 54.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Promino Nutritional Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Promino Nutritional Sciences Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Promino Nutritional Sciences Inc Frequently Asked Questions

What is Promino Nutritional Sciences Inc(FRA:93X)'s stock price today?
The current price of FRA:93X is €0.16. The 52 week high of FRA:93X is €0.50 and 52 week low is €0.05.
When is next earnings date of Promino Nutritional Sciences Inc(FRA:93X)?
The next earnings date of Promino Nutritional Sciences Inc(FRA:93X) is .
Does Promino Nutritional Sciences Inc(FRA:93X) pay dividends? If so, how much?
Promino Nutritional Sciences Inc(FRA:93X) does not pay dividend.

Press Release

Subject Date
No Press Release